FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Clonidine hydrochloride 250micrograms m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Trimetaphan camsylate 50mg/mL injection solution 5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nisoldipine 20mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nisoldipine 30mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Isosorbide mononitrate+aspirin 60mg/150mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Isosorbide mononitrate+aspirin 60mg/75mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 30 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Isosorbide dinitrate 30mg transdermal spray VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cinnarizine 75 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely inositol niacinate 200 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Co-dergocrine mesylate 4.5mg tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Epinephrine 1mg/mL injection solution 5mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Dobutamine 12.5mg/mL infusion concentrate 20mL vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Dobutamine 50mg/mL infusion concentrate 5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Metaraminol 10mg/1mL injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Methoxamine hydrochloride 20mg/1mL injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Heparin calcium 25,000iu/mL injection solution 0.5mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Certoparin sodium 10,000iu/mL injection solution 0.3mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Reviparin sodium 5728iu/mL injection solution 0.25mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ticlopidine hydrochloride 250 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 50 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely cerivastatin sodium 100 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cerivastatin sodium 200 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cerivastatin sodium 300 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cerivastatin sodium 400 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Salbutamol 5mg/50mL injection VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Salbutamol 200micrograms/blister disks+disk inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Salbutamol 400micrograms/blister disks+disk inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Salbutamol 200micrograms/blister disks refill VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Salbutamol 400micrograms/blister disks refill VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Salbutamol 100micrograms breath-actuated aerosol inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Terbutaline sulfate 200mg/20mL nebulizer solution VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Terbutaline sulfate 250micrograms spacer inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Terbutaline sulfate 7.5mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ephedrine hydrochloride 15mg/5mL elixir VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ipratropium bromide 20micrograms breath-actuated aerosol inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ipratropium bromide 40micrograms inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Oxitropium bromide 100micrograms breath-actuated aerosol inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely theophylline 125 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely theophylline monohydrate (as theophylline sodium glycinate) 12 milligram/1 milliliter conventional release oral solution VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Fenoterol hydrobromide+ipratropium bromide 100micrograms/40micrograms inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Fenoterol hydrobromide+ipratropium bromide 100micrograms/40micrograms breath-actuated aerosol inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Beclomethasone dipropionate+salbutamol 100micrograms/200micrograms pediatric inhalation capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Beclomethasone dipropionate+salbutamol 50micrograms/100micrograms inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sodium cromoglycate 5mg breath-actuated aerosol inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nedocromil sodium 2 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Nedocromil sodium 2mg inhaler+spacer VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Azatadine maleate 500micrograms/5mL syrup VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Brompheniramine maleate 2mg/5mL elixir VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Clemastine 500micrograms/5mL elixir VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Colfosceril palmitate 108mg sterile powder for suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Codeine phosphate 3mg/5mL pediatric linctus VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely flunitrazepam 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely dipotassium clorazepate 15 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amobarbital 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Chlorpromazine hydrochloride 100mg/5mL s/f suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Chlorpromazine hydrochloride 25mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 2.5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely oxypertine 10 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely oxypertine 40 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely pimozide 2 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 25 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 50 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 100 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine 5 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine 20 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely thioridazine (as thioridazine hydrochloride) 5 milligram/1 milliliter conventional release oral solution VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely loxapine 10 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely loxapine 25 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely loxapine 50 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Fluphenazine decanoate 25mg/mL injection solution 1mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Fluphenazine decanoate 25mg/mL injection solution 2mL prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Fluphenazine decanoate 25mg/mL injection solution 10mL vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Amitriptyline hydrochloride 25mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Amitriptyline hydrochloride 50mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Clomipramine hydrochloride 12.5mg/mL injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 each conventional release oral capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely doxepin (as doxepin hydrochloride) 75 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely maprotiline hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely maprotiline hydrochloride 25 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely maprotiline hydrochloride 50 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely maprotiline hydrochloride 75 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely mianserin hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amoxapine 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amoxapine 100 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier

Start Previous Page 72 of 304 Next End

This concept is not in any reference sets

Back to Start